TY - JOUR
T1 - Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users
AU - Thiede, H.
AU - Romero, M.
AU - Bordelon, K.
AU - Hagan, H.
AU - Murrill, C.
N1 - Funding Information:
This study was funded through a cooperative agreement with the Centers for Disease Control and Prevention (U62/CCU006260). We would like to thank Jim Harms and staff at the King County Department of Adult and Juvenile Detention, Mary Dirksen and the Jail Health Services Program, Linda Oakley and the Kiwi Study staff, the Public Health—Seattle and King County Laboratory, and the Kiwi Study participants for their contribution to this study.
PY - 2001
Y1 - 2001
N2 - Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington; to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12%) reported injection drug use, and 201 of the IDUs (40%) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2%; in the past 6 months, 69% reported two or more shooting partners, 72% used a cooker after someone else, 60% shared a syringe to divide up drugs, and 62% injected with used needles. Only 37% reported being hepatitis C seropositive, and 8% reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.
AB - Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington; to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12%) reported injection drug use, and 201 of the IDUs (40%) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2%; in the past 6 months, 69% reported two or more shooting partners, 72% used a cooker after someone else, 60% shared a syringe to divide up drugs, and 62% injected with used needles. Only 37% reported being hepatitis C seropositive, and 8% reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.
KW - Correctional Facility
KW - HIV
KW - Hepatitis B and C Prevention
KW - Injection Drug Users
KW - Risk Behaviors
UR - http://www.scopus.com/inward/record.url?scp=0034971686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034971686&partnerID=8YFLogxK
U2 - 10.1093/jurban/78.2.264
DO - 10.1093/jurban/78.2.264
M3 - Article
C2 - 11419580
AN - SCOPUS:0034971686
SN - 1099-3460
VL - 78
SP - 264
EP - 278
JO - Journal of Urban Health
JF - Journal of Urban Health
IS - 2
ER -